• Samsung Biologics scheduled its financial results disclosure for the nine months ended Sept. 30, 2026 on Oct. 21, 2026.
• Results materials set for publication on https://www.samsungbiologics.com following the disclosure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsung Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007800351), on October 07, 2026, and is solely responsible for the information contained therein.